Articles

Dabrafenib and trametinib in Langerhans cell histiocytosis and other histiocytic disorders

Cincinnati Children’s Hospital Medical Center Residency Training Program, Cincinnati
Cincinnati Children’s Hospital Medical Center Residency Training Program, Cincinnati
University of Cincinnati College of Medicine, Division of Radiology, Cincinnati Children’s Hospital Medical Center, Cincinnati
Division of Hematology and Oncology, Cook Children’s Hospital, Fort Worth, Texas
University of Cincinnati College of Medicine, Division of Bone Marrow Transplant and Immune Deficiency, Cincinnati Children’s Hospital Medical Center, Cincinnati
University of Cincinnati College of Medicine, Division of Bone Marrow Transplant and Immune Deficiency, Cincinnati Children’s Hospital Medical Center, Cincinnati
University of Cincinnati College of Medicine, Division of Bone Marrow Transplant and Immune Deficiency, Cincinnati Children’s Hospital Medical Center, Cincinnati
University of Cincinnati College of Medicine, Division of Pathology, Cincinnati Children’s Hospital Medical Center, Cincinnati
University of Cincinnati College of Medicine, Division of Pathology, Cincinnati Children’s Hospital Medical Center, Cincinnati
University of Cincinnati College of Medicine, Division of Radiology, Cincinnati Children’s Hospital Medical Center, Cincinnati
University of Cincinnati College of Medicine, Division of Bone Marrow Transplant and Immune Deficiency, Cincinnati Children’s Hospital Medical Center, Cincinnati
University of Cincinnati College of Medicine, Division of Bone Marrow Transplant and Immune Deficiency, Cincinnati Children’s Hospital Medical Center, Cincinnati
University of Cincinnati College of Medicine, Division of Pathology, Cincinnati Children’s Hospital Medical Center, Cincinnati
University of Cincinnati College of Medicine, Division of Bone Marrow Transplant and Immune Deficiency, Cincinnati Children’s Hospital Medical Center, Cincinnati
Haematologica Early view Sep 21, 2023 https://doi.org/10.3324/haematol.2023.283295